Article
The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.
Transplant immunology - 1 Jun 2017
Horio Tomohiro, Mizuno Shohei, Uchino Kaori, Mizutani Motonori, Hanamura Ichiro, Espinoza J Luis, Onizuka Makoto, Kashiwase Koichi, Morishima Yasuo, Fukuda Takahiro, Kodera Yoshihisa, Doki Noriko, Miyamura Koichi, Mori Takehiko, Takami Akiyoshi
Abstract excerpt
The chemokine receptor CCR5 plays roles in the trafficking of effector cells towards the site of inflammation. We retrospectively examined the impact of the CCR5 variation (rs1800023, -2086A>G) on transplant outcomes in a cohort of 329 patients who underwent unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies through the Japan Marrow Donor Program. A multivariate analysis showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
